{"id":{"repo_id":"clemson","oai_identifier":"oai:open.clemson.edu:all_theses-4392"},"canonical_url":"https://search.ndltd.org/etd/clemson/oai:open.clemson.edu:all_theses-4392","repository":{"repo_id":"clemson","name":"Clemson University","base_url":"https://open.clemson.edu/do/oai/"},"display":{"title":"Role of CYP2B6 in Perfluorooctanesulfonic Acid (PFOS)-Induced Toxicity and Non Alcoholic Fatty Liver Disease (NAFLD)","abstract":"Perfluorooctanesulfonic acid (PFOS) is a persistent, toxic fluorosurfactant foam used in firefighting foams, textiles, and other industrial products. Human CYP2B6 is predominantly expressed in the liver and responsible for metabolizing xeno- and endobiotics. CYP2B is induced by PFOS and high-fat diets in rodents and therefore it was hypothesized that CYP2B contributed to PFOS-induced steatosis. Cyp2b-9/10/13-null (Cyp2b-null) and humanized CYP2B6-Tg (hCYP2B6-Tg) mice were treated with PFOS (0, 1, or 10 mg/kg/day) by oral gavage in mice fed either a typical chow diet (ND) or a high-fat diet (HFD). Our studies show human CYP2B6 is also inducible in vivo by PFOS. In addition, three ND-fed hCYP2B6-Tg female mice treated with 10 mg/kg/day PFOS died during the exposure period. Similarly treated HFD-fed mice did not die. Interestingly, hCYP2B6-Tg mice retained significantly more PFOS in the serum and liver than Cyp2b-null mice presumably leading to the observed toxicity. Serum PFOS retention was significantly reduced in the HFD-fed hCYP2B6-Tg mice, which is the opposite trend observed in HFD-fed Cyp2b-null mice. Hepatotoxicity biomarkers, ALT and ALP, were higher in PFOS-treated mice and lowered by a HFD. However, PFOS combined with a HFD exacerbated hepatic lipid accumulation in all mice, especially in the hCYP2B6-Tg mice with significant disruption of key lipid metabolism genes such as Srebp1, Pparg, and Cpt1a. In conclusion, CYP2B6 is induced by PFOS and protects from PFOS-mediated steatosis in ND-fed mice; however, it’s presence increases hepatic triglyceride content in HFD-PFOS co-treated mice and increases toxicity in ND-fed mice.","abstract_html":"Perfluorooctanesulfonic acid (PFOS) is a persistent, toxic fluorosurfactant foam used in firefighting foams, textiles, and other industrial products. Human CYP2B6 is predominantly expressed in the liver and responsible for metabolizing xeno- and endobiotics. CYP2B is induced by PFOS and high-fat diets in rodents and therefore it was hypothesized that CYP2B contributed to PFOS-induced steatosis. Cyp2b-9/10/13-null (Cyp2b-null) and humanized CYP2B6-Tg (hCYP2B6-Tg) mice were treated with PFOS (0, 1, or 10 mg/kg/day) by oral gavage in mice fed either a typical chow diet (ND) or a high-fat diet (HFD). Our studies show human CYP2B6 is also inducible in vivo by PFOS. In addition, three ND-fed hCYP2B6-Tg female mice treated with 10 mg/kg/day PFOS died during the exposure period. Similarly treated HFD-fed mice did not die. Interestingly, hCYP2B6-Tg mice retained significantly more PFOS in the serum and liver than Cyp2b-null mice presumably leading to the observed toxicity. Serum PFOS retention was significantly reduced in the HFD-fed hCYP2B6-Tg mice, which is the opposite trend observed in HFD-fed Cyp2b-null mice. Hepatotoxicity biomarkers, ALT and ALP, were higher in PFOS-treated mice and lowered by a HFD. However, PFOS combined with a HFD exacerbated hepatic lipid accumulation in all mice, especially in the hCYP2B6-Tg mice with significant disruption of key lipid metabolism genes such as Srebp1, Pparg, and Cpt1a. In conclusion, CYP2B6 is induced by PFOS and protects from PFOS-mediated steatosis in ND-fed mice; however, it’s presence increases hepatic triglyceride content in HFD-PFOS co-treated mice and increases toxicity in ND-fed mice.","abstract_has_math":false,"creators":["Hamilton, Matthew C"],"institution":null,"degree_name":"Master of Science (MS)","degree_level":"Thesis","degree_discipline":"Biological Sciences","degree_department":null,"school":null,"contributors":["William S Baldwin","Lisa Bain","Charles Rice"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:23:27Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://open.clemson.edu/all_theses/3385","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://open.clemson.edu/all_theses/3385","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.clemson.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Aopen.clemson.edu%3Aall_theses-4392","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["William S Baldwin","Lisa Bain","Charles Rice"]},{"key":"dc:creator","label":"Author","values":["Hamilton, Matthew C"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2020-08-01T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biological Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MS)"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://open.clemson.edu/all_theses/3385"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Perfluorooctanesulfonic acid (PFOS) is a persistent, toxic fluorosurfactant foam used in firefighting foams, textiles, and other industrial products. Human CYP2B6 is predominantly expressed in the liver and responsible for metabolizing xeno- and endobiotics. CYP2B is induced by PFOS and high-fat diets in rodents and therefore it was hypothesized that CYP2B contributed to PFOS-induced steatosis. Cyp2b-9/10/13-null (Cyp2b-null) and humanized CYP2B6-Tg (hCYP2B6-Tg) mice were treated with PFOS (0, 1, or 10 mg/kg/day) by oral gavage in mice fed either a typical chow diet (ND) or a high-fat diet (HFD). Our studies show human CYP2B6 is also inducible in vivo by PFOS. In addition, three ND-fed hCYP2B6-Tg female mice treated with 10 mg/kg/day PFOS died during the exposure period. Similarly treated HFD-fed mice did not die. Interestingly, hCYP2B6-Tg mice retained significantly more PFOS in the serum and liver than Cyp2b-null mice presumably leading to the observed toxicity. Serum PFOS retention was significantly reduced in the HFD-fed hCYP2B6-Tg mice, which is the opposite trend observed in HFD-fed Cyp2b-null mice. Hepatotoxicity biomarkers, ALT and ALP, were higher in PFOS-treated mice and lowered by a HFD. However, PFOS combined with a HFD exacerbated hepatic lipid accumulation in all mice, especially in the hCYP2B6-Tg mice with significant disruption of key lipid metabolism genes such as Srebp1, Pparg, and Cpt1a. In conclusion, CYP2B6 is induced by PFOS and protects from PFOS-mediated steatosis in ND-fed mice; however, it’s presence increases hepatic triglyceride content in HFD-PFOS co-treated mice and increases toxicity in ND-fed mice."]},{"key":"dc:title","label":"Title","values":["Role of CYP2B6 in Perfluorooctanesulfonic Acid (PFOS)-Induced Toxicity and Non Alcoholic Fatty Liver Disease (NAFLD)"]}]}],"canonical_facts":{"dc:contributor":["William S Baldwin","Lisa Bain","Charles Rice"],"dc:creator":["Hamilton, Matthew C"],"dc:date.created":["2020-08-01T07:00:00Z"],"dc:description.abstract":["Perfluorooctanesulfonic acid (PFOS) is a persistent, toxic fluorosurfactant foam used in firefighting foams, textiles, and other industrial products. Human CYP2B6 is predominantly expressed in the liver and responsible for metabolizing xeno- and endobiotics. CYP2B is induced by PFOS and high-fat diets in rodents and therefore it was hypothesized that CYP2B contributed to PFOS-induced steatosis. Cyp2b-9/10/13-null (Cyp2b-null) and humanized CYP2B6-Tg (hCYP2B6-Tg) mice were treated with PFOS (0, 1, or 10 mg/kg/day) by oral gavage in mice fed either a typical chow diet (ND) or a high-fat diet (HFD). Our studies show human CYP2B6 is also inducible in vivo by PFOS. In addition, three ND-fed hCYP2B6-Tg female mice treated with 10 mg/kg/day PFOS died during the exposure period. Similarly treated HFD-fed mice did not die. Interestingly, hCYP2B6-Tg mice retained significantly more PFOS in the serum and liver than Cyp2b-null mice presumably leading to the observed toxicity. Serum PFOS retention was significantly reduced in the HFD-fed hCYP2B6-Tg mice, which is the opposite trend observed in HFD-fed Cyp2b-null mice. Hepatotoxicity biomarkers, ALT and ALP, were higher in PFOS-treated mice and lowered by a HFD. However, PFOS combined with a HFD exacerbated hepatic lipid accumulation in all mice, especially in the hCYP2B6-Tg mice with significant disruption of key lipid metabolism genes such as Srebp1, Pparg, and Cpt1a. In conclusion, CYP2B6 is induced by PFOS and protects from PFOS-mediated steatosis in ND-fed mice; however, it’s presence increases hepatic triglyceride content in HFD-PFOS co-treated mice and increases toxicity in ND-fed mice."],"dc:identifier":["https://open.clemson.edu/all_theses/3385"],"dc:title":["Role of CYP2B6 in Perfluorooctanesulfonic Acid (PFOS)-Induced Toxicity and Non Alcoholic Fatty Liver Disease (NAFLD)"],"thesis:degree_discipline":["Biological Sciences"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science (MS)"]},"updated_at":"2026-11-19T07:23:27Z"}